Suppr超能文献

择期手术术前口服碳水化合物治疗的随机对照试验的荟萃分析。

A meta-analysis of randomised controlled trials on preoperative oral carbohydrate treatment in elective surgery.

机构信息

Division of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre National Institute for Health Research Biomedical Research Unit, Nottingham University Hospitals, Queen's Medical Centre, Nottingham NG7 2UH, UK.

出版信息

Clin Nutr. 2013 Feb;32(1):34-44. doi: 10.1016/j.clnu.2012.10.011. Epub 2012 Nov 7.

Abstract

BACKGROUND & AIMS: Whilst preoperative carbohydrate treatment (PCT) results in beneficial physiological effects, the effects on postoperative clinical outcomes remain unclear and were studied in this meta-analysis.

METHODS

Prospective studies that randomised adult non-diabetic patients to either PCT (≥50 g oral carbohydrates 2-4 h pre-anaesthesia) or control (fasted/placebo) were included. The primary outcome was length of hospital stay. Secondary outcomes included development of postoperative insulin resistance, complications, nausea and vomiting. Methodological quality was assessed using GRADEpro® software.

RESULTS

Twenty-one randomised studies of 1685 patients (733 PCT: 952 control) were included. No overall difference in length of stay was noted for analysis of all studies or subgroups of patients undergoing surgery with an expected hospital stay ≤2 days or orthopaedic procedures. However, patients undergoing major abdominal surgery following PCT had reduced length of stay [mean difference, 95% confidence interval: -1.08 (-1.87 to -0.29); I² = 60%, p = 0.007]. PCT reduced postoperative insulin resistance with no effects on in-hospital complications over control (risk ratio, 95% confidence interval, 0.88 (0.50-1.53), I² = 41%; p = 0.640). There was significant heterogeneity amongst studies and, therefore, quality of evidence was low to moderate.

CONCLUSIONS

PCT may be associated with reduced length of stay in patients undergoing major abdominal surgery, however, the included studies were of low to moderate quality.

摘要

背景与目的

尽管术前碳水化合物治疗(PCT)可产生有益的生理效应,但术后临床结局的影响仍不清楚,本荟萃分析对此进行了研究。

方法

纳入将成年非糖尿病患者随机分配至 PCT(麻醉前 2-4 小时口服≥50g 碳水化合物)或对照组(禁食/安慰剂)的前瞻性研究。主要结局为住院时间。次要结局包括术后胰岛素抵抗的发展、并发症、恶心和呕吐。使用 GRADEpro®软件评估方法学质量。

结果

纳入了 21 项涉及 1685 名患者(733 名 PCT:952 名对照)的随机研究。所有研究或预计住院时间≤2 天或骨科手术的患者亚组分析均未发现住院时间存在总体差异。然而,PCT 后行大腹部手术的患者住院时间缩短[平均差异,95%置信区间:-1.08(-1.87 至-0.29);I²=60%,p=0.007]。PCT 降低了术后胰岛素抵抗,但与对照组相比,对院内并发症无影响(风险比,95%置信区间,0.88(0.50-1.53),I²=41%;p=0.640)。研究间存在显著异质性,因此证据质量为低到中度。

结论

PCT 可能与大腹部手术患者的住院时间缩短相关,但纳入的研究质量为低到中度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验